Literature DB >> 6855813

Absence of maternal contamination of chorionic villi used for fetal-gene analysis.

R G Elles, R Williamson, M Niazi, D V Coleman, D Horwell.   

Abstract

Chorionic villi can be obtained by direct transcervical aspiration at 9 to 10 weeks' gestation and used for analysis of fetal DNA. However, for the method to be reliable, there must be no detectable contamination by maternal DNA. To investigate the question of contamination, we compared the DNA of chorionic villi from five fetuses with that obtained from maternal lymphocytes, using the restriction endonuclease Taql and specific DNA probes for a pair of alleles on the X chromosome. The alleles yield fragments of different lengths when digested with Taql (length polymorphism), which can be demonstrated by electrophoresis and hybridization with the radioactive DNA probes. If the pattern obtained with the chorionic DNA is different from that obtained with the maternal DNA, contamination is not present. In two cases the fetal DNA of the chorionic villi was shown to be uncontaminated by maternal tissue. In one of these cases the mother was heterozygous and the fetus was homozygous; in the other the mother was homozygous and the fetus was heterozygous. In three other cases no definitive conclusions could be drawn, because the genotypes of the fetus and mother were identical. We conclude that chorionic villi at 9 to 10 weeks' gestation are a source of fetal DNA that can be used for gene analysis, with no detectable contamination by maternal DNA.

Mesh:

Substances:

Year:  1983        PMID: 6855813     DOI: 10.1056/NEJM198306163082401

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  12 in total

Review 1.  Nebuliser therapy in childhood.

Authors:  P W Barry; C O'Callaghan
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Prenatal diagnosis of sickle cell disease by the technique of PCR.

Authors:  Praneeta J Singh; A C Shrivastava; A V Shrikhande
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-08       Impact factor: 0.900

3.  Chorionic villus sampling: first trimester prenatal diagnosis.

Authors:  A T Bombard; J L Simpson; S Elias; A O Martin
Journal:  Indian J Pediatr       Date:  1986 Nov-Dec       Impact factor: 1.967

4.  Prenatal diagnosis of genetic disease by chorionic villi sampling.

Authors:  I Bartels; I Hansmann
Journal:  Indian J Pediatr       Date:  1986 Jul-Aug       Impact factor: 1.967

5.  Cytogenetic analysis of chorionic villi: a technical assessment.

Authors:  M J Vekemans; T B Perry
Journal:  Hum Genet       Date:  1986-04       Impact factor: 4.132

6.  DNA analysis of first-trimester chorionic villous biopsies: test for maternal contamination.

Authors:  B de Martinville; K J Blakemore; M J Mahoney; U Francke
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

7.  Towards a medical eugenics?

Authors:  M Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-11

8.  DNA markers and Duchenne muscular dystrophy.

Authors:  P S Harper
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

9.  Diagnostic application of first trimester trophoblast sampling in 100 pregnancies.

Authors:  G Simoni; B Brambati; C Danesino; G L Terzoli; L Romitti; F Rossella; M Fraccaro
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Clinical use of DNA markers linked to the gene for Duchenne muscular dystrophy.

Authors:  M E Pembrey; K E Davies; R M Winter; R G Elles; R Williamson; T A Fazzone; C Walker
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.